Anavex Life Sciences Corporation (AVXL)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.38M | -14.19M | -13.53M | -12.65M | -11.29M | -12.52M | -14.73M | -14.34M |
| Pre Tax Income | -12.99M | -13.06M | -11.24M | -10.21M | -8.54M | -10.44M | -12.28M | -11.74M |
| Net Income | -12.97M | -13.11M | -11.28M | -10.15M | -8.62M | -10.55M | -12.21M | -11.62M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -14.63M | -13.44M | -13.93M | -11.98M | -10.7M | -12.05M | -14.2M | -13.56M |
| EBITDA | -15.38M | -14.19M | -13.53M | -12.65M | -11.29M | -12.52M | -14.73M | -14.34M |
| Year End September 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 54k | 0 | 0 | 0 |
| Operating Income | -15.68M | -19.33M | -29.11M | -31.09M | -41.95M | -50.99M | -55.76M | -52.88M |
| Pre Tax Income | -13.4M | -17.38M | -26.21M | -26.26M | -37.64M | -47.62M | -47.5M | -43M |
| Net Income | -13.46M | -17.45M | -26.3M | -26.28M | -37.91M | -47.98M | -47.51M | -43M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.311 | -0.38 | -0.499 | -0.424 | -0.499 | -0.616 | -0.58 | -0.507 |
| EBIT | -13.44M | -17.59M | -26.23M | -26.56M | -37.4M | -47.66M | -53.01M | -50.51M |
| EBITDA | -15.68M | -19.33M | -29.11M | -31.09M | -41.95M | -50.99M | -55.76M | -52.88M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
